Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000233955

Medchemexpress LLC (+)-Mepivacaine | 24358-84-7 | 98.1% | 25 MG
SDP

Catalog No. 5000233955
Encompass_Preferred

(+)-Mepivacaine is the optically active (+) enantiomer of mepivacaine, an amide-type local anesthetic that inhibits voltage-gated sodium channels. It is supplied as a research-grade solid for laboratory pharmacology and electrophysiology studies.

  • Optically active (+) enantiomer.
  • Amide-type local anesthetic; sodium channel inhibitor.
  • Useful for electrophysiology and pharmacology research.
  • Molecular formula C15H22N2O; molecular weight 246.35.
  • CAS 24358-84-7.
  • Soluble in DMSO (100 mg/mL); formulation guidance for co-solvent systems: ≥2.5 mg/mL.
  • Storage: powder sealed, away from moisture and light; in solvent: -80°C (6 months), -20°C (1 month).

Catalog No. 50-002-33955 Supplier Medchemexpress LLC Supplier No. HY11996125MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

(+)-Mepivacaine is the optically active (+) enantiomer of mepivacaine, an amide-type local anesthetic that inhibits voltage-gated sodium channels. It is supplied as a research-grade solid for laboratory pharmacology and electrophysiology studies.

  • Optically active (+) enantiomer.
  • Amide-type local anesthetic; sodium channel inhibitor.
  • Useful for electrophysiology and pharmacology research.
  • Molecular formula C15H22N2O; molecular weight 246.35.
  • CAS 24358-84-7.
  • Soluble in DMSO (100 mg/mL); formulation guidance for co-solvent systems: ≥2.5 mg/mL.
  • Storage: powder sealed, away from moisture and light; in solvent: -80°C (6 months), -20°C (1 month).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.